ASSESSMENT OF MORPHOLOGICAL PARAMETERS DEFINING RISK STRATIFICATION IN CUTANEOUS BASAL CELL CARCINOMA. A SINGLE-CENTRE STUDY

Authors

  • M FATIMA Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
  • F KHALID Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
  • M AHSAN Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
  • O CHUGHTAI Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan
  • S RATHORE Department of Histopathology, Chughtai Institute of Pathology, Lahore, Pakistan

DOI:

https://doi.org/10.54112/pjicm.v5i02.144

Keywords:

Basal Cell Carcinoma; Depth of Invasion; Pakistan; Risk Stratification; Skin Cancer

Abstract

Background: Basal cell carcinoma (BCC) is the most common skin malignancy worldwide, yet its clinical risk is heterogeneous and strongly influenced by histomorphological features. Data from Pakistan are limited, and local evidence is needed to inform treatment strategies based on histology-defined risk. Objective: To evaluate histomorphological parameters for risk stratification in cutaneous basal cell carcinoma in a Pakistani population. Study Design: Single-centre observational study. Setting: Department of Histopathology, Chughtai Lab, Pakistan. Duration of Study: 1 March 2023 to 30 September 2024. Methods: Histopathology reports of 382 unique BCC specimens were retrieved from the laboratory information system (Nexus Pro). Extracted variables included age, gender, anatomical site, and maximum tumor diameter. Histological subtypes were categorized as nodular, infiltrative, superficial, keratotic, adenoid, micronodular, or mixed. Depth of invasion was measured from the reconstructed epidermal surface to the deepest tumor nest and stratified into clinically relevant groups. Adverse features, including perineural invasion (PNI), lymphovascular invasion (LVI), and ulceration, were documented. High-risk histology was defined a priori as any infiltrative or micronodular component (pure or mixed). Descriptive statistics were performed in line with STROBE guidance. Results: The mean age was 63.11 ± 14.48 years; 50.5% were female, and 63.9% were ≥60 years. The majority of lesions arose on the head and neck. Nodular BCC was the most common pure subtype (62.3%), followed by infiltrative (19.9%) and superficial (7.9%); mixed subtypes constituted 7.3%. Depth of invasion was ≥7 mm in 52.4% of tumors, while 36.2% measured ≥20 mm clinically. Adverse features included PNI in 6.5%, LVI in 0.5%, and ulceration in 86.9%. Overall, 25.1% of cases were classified as high-risk and 74.9% as low-risk histology. Conclusion: Nodular BCC was the predominant subtype, but one in four tumors exhibited high-risk histology. A substantial proportion of lesions were large (≥20 mm) or deeply invasive (≥7 mm) at presentation. Morphology-based risk stratification is practical for routine reporting and can inform surgical margins, surveillance intensity, and multidisciplinary referral decisions. Early detection, particularly for head and neck lesions, may reduce the burden of advanced disease.

References

Kuchkuntla A. Metastatic basal cell carcinoma. J Oncol Res Rev Rep 2021:1-2. https://doi.org/10.47363/jonrr/2021(2)148

Cohen P., Erickson C., Uebelhoer N., & Calame A. Tattoo-associated basal cell carcinoma: coincident or coincidence. Biomedicine Hub 2020;5(2):1-8. https://doi.org/10.1159/000508208

Mustofa A., Sholikah T., Niari T., & Rahmawati Y.. Basal cell carcinoma. Magna Medica Berkala Ilmiah Kedokteran Dan Kesehatan 2022;9(1):62. https://doi.org/10.26714/magnamed.9.1.2022.62-68

Ciążyńska M., Pabianek M., Sławińska M., Reich A., Lewandowski B., Szczepaniak K.et al.. Risk factors and clinicopathological features for the development of subsequent primary cutaneous squamous and basal cell carcinomas. Cancers 2022;14(13):3069. https://doi.org/10.3390/cancers14133069

Cocuz I., Popelea M., Niculescu R., Manea A., Sabău A., Tinca A.et al.. Pathophysiology, histopathology, and differential diagnostics of basal cell carcinoma and cutaneous squamous cell carcinoma—an update from the pathologist's point of view. International Journal of Molecular Sciences 2024;25(4):2220. https://doi.org/10.3390/ijms25042220

Dika E., Scarfì F., Ferracin M., Broseghini E., Marcelli E., Bortolani B.et al. Basal cell carcinoma: a comprehensive review. International Journal of Molecular Sciences 2020;21(15):5572. https://doi.org/10.3390/ijms21155572

Fernández-Flores Á. and Cassarino D. Merkel cells in extraocular sebaceous carcinoma. Journal of Cutaneous Pathology 2018;46(3):171-174. https://doi.org/10.1111/cup.13381

Murgia G., Denaro N., Boggio F., Nazzaro G., Benzecry V., Bortoluzzi P., et al. Basosquamous carcinoma: comprehensive clinical and histopathological aspects, novel imaging tools, and therapeutic approaches. Cells 2023;12(23):2737. https://doi.org/10.3390/cells12232737

Shibuya T., Takahashi G., & Kan T. Basal cell carcinoma of the prostate: a casereport and review of the literature. Molecular and Clinical Oncology 2018. https://doi.org/10.3892/mco.2018.1754

Cocuz I., Cocuz M., Sabău A., Niculescu R., Tinca A., Vunvulea V.et al.. An up-to-date correlation of epidemiological and histopathological characteristics of basal cell carcinoma of the skin in a county hospital in Romania. Dermatopathology 2022;9(2):183-195. https://doi.org/10.3390/dermatopathology9020023

Surkov Y., Serebryakova I., Kuzinova Y., Konopatskova O., Safronov D., Kapralov S.et al.. Multimodal method for differentiating various clinical forms of basal cell carcinoma and benign neoplasms in vivo. Diagnostics 2024;14(2):202. https://doi.org/10.3390/diagnostics14020202

Masoomian M., Downes M., Sweet J., Cheung C., Evans A., Fleshner N.et al.. Concordance of biopsy and prostatectomy diagnosis of intraductal and cribriform carcinoma in a prospectively collected data set. Histopathology 2018;74(3):474-482. https://doi.org/10.1111/his.13747

Dika E., Scarfì F., Ferracin M., Broseghini E., Marcelli E., Bortolani B.et al. Basal cell carcinoma: a comprehensive review. International Journal of Molecular Sciences 2020;21(15):5572. https://doi.org/10.3390/ijms21155572

Wisdorf K., Rokohl A., Fan W., & Heindl L. Recurrence risk of basal cell carcinoma of the eyelid about demographic and clinical patient data. 2024. https://doi.org/10.21203/rs.3.rs-4357234/v1

Akhlaghdoust M., Safari S., Davoodi P., Soleimani S., & Ebadian E.. The relation between eyelid tumors and demographic variables. Oftalmologicheskii Zhurnal 2021;93(4):57-60. https://doi.org/10.31288/oftalmolzh202145760

Cohen P. Cutaneous basal cell carcinoma in situ: a case series. Cureus 2022. https://doi.org/10.7759/cureus.29479

Asif M, Mamoon N, Ali Z, Akhtar F. Epidemiological and excision margin status of basal cell carcinoma: three years' Armed Forces Institute of Pathology experience in Pakistan. Asian Pac J Cancer Prev. 2010 Jan 1;11(5):1421-3.

Mantese SA, Berbert AL, Gomides MD, Rocha A. Basal cell carcinoma-Analysis of 300 cases observed in Uberlândia-MG, Brazil. Anais Brasileiros de Dermatologia. 2006;81:136-42.

Unar A, Khan H, Zahid N, Khan MA, Fatima S, Shaikh SA, Rahman MF. Association of the Depth of Invasion With Recurrence Rates of Basal Cell Carcinoma in a Tertiary Health Care Facility: A Retrospective Study Over a Period of Six Years. Cureus. 2023 Mar 17;15(3):e36276. https://doi.org/10.7759/cureus.36276.

Afridi RA, Ahmed E, Khan SA, Ali A. Demographics of basal cell carcinoma and its surgical management. Journal of Ayub Medical College Abbottabad. 2012 Dec 1;24(3-4):141-3. https://www.ayubmed.edu.pk/JAMC/24-3/Afridi.pdf

Paul S, Knight A. The Importance of Basal Cell Carcinoma Risk Stratification and Potential Future Pathways JMIR Dermatol 2023;6:e50309 https://doi.org/10.2196/50309

Vornicescu C, Șenilă SC, Bejinariu NI, Vesa ȘC, Boșca AB, Chirilă DN, Melincovici CS, Sorițău O, Mihu CM. Predictive factors for the recurrence of surgically excised basal cell carcinomas: a retrospective clinical and immunopathological pilot study. Experimental and therapeutic medicine. 2021 Nov;22(5):1336.. https://doi.org/10.3892/etm.2021.10771

Walvir NM, Makhdoomi R, Abeer I, Ganaie F, Maqsood S. A complete spectrum of congenital cystic adenomatoid malformation of the lung, deceptive clinical presentations and histological surprises; a single institutional study from a tertiary care hospital in North India. Lung India. 2023 Sep 1;40(5):423-8.

Downloads

Published

2025-07-14

How to Cite

FATIMA , M., KHALID , F., AHSAN , M., CHUGHTAI , O., & RATHORE , S. (2025). ASSESSMENT OF MORPHOLOGICAL PARAMETERS DEFINING RISK STRATIFICATION IN CUTANEOUS BASAL CELL CARCINOMA. A SINGLE-CENTRE STUDY. Pakistan Journal of Intensive Care Medicine, 5(02), 144. https://doi.org/10.54112/pjicm.v5i02.144

Issue

Section

Original Research Articles